Farms.com Home   News

AFBF Urges USDA to Use Emergency Authority to Ensure Fair Pricing for Dairy Farmers

The American Farm Bureau Federation sent a letter today to U.S. Department of Agriculture Secretary Tom Vilsack urging the agency to issue a final decision on an emergency basis to speed the implementation of the “higher-of” Class I mover formula to buffer dairy farmers from further losses during the forthcoming Federal Milk Marketing Order rulemaking process.

“The comprehensive process of amending federal orders, though important, means dairy farmers remain stuck with current pricing regulations until USDA publishes a final rule,” Sam Kieffer, AFBF vice president of public policy, said in the letter, which also notes that FMMO reform is in step five of a 12-step process. “The current Class I mover was a well-intentioned policy misstep that has reduced dairy farmers’ checks, with little relief in sight. Emergency implementation of the ‘higher-of’ Class I mover formula will help buffer against persistent losses associated with mistaken and outdated policies that have left dairy farmers struggling to make ends meet.”

AFBF economist Danny Munch read the letter into the official record as the last witness of the hearing process. AFBF has participated in the full 49 days of the hearing, which began on Aug. 23, 2023.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.